Using patients’ samples from the Cohort 1 (Table 1) following clinical diagnosis of preeclampsia, we measured plasma FKBPL and CD44 concentration (n = 18, preeclampsia; n = 14, control) as well as secreted FKBPL from MSCs isolated from pregnant women with preeclampsia (n = 3) and normotensive controls (n = 3). The gene discussed is CD44; the disease is preeclampsia.